drugset / Trial / NCT06512363

A Study of Ramelteon in Chinese Patients With Chronic Insomnia

NCT06512363

Phase 3 Not yet recruiting 280 enrolled Nanjing Chia-tai Tianqing Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of Ramelteon in chinese patients with chronic insomnia. Efficacy will be evaluated on objective and subjective sleep parameters.

Timeline

Start
2024-08
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramelteon Unknown 8 mg Oral

Indications